Journal of Cancer Research and Therapeutics' 2026 Journal Metrics Score is 1.4, ranking Q2 in Otorhinolaryngology. Two-year citation average from OpenAlex data, updated August 2026.
Bookmark this page — track observed submission-to-acceptance timing, FWCI and field-normalized citation data for this journal in one view.
Journal Metrics Score 2026 · 2021–2024 window citedness 1.31.
Middle 50%: 96–254 days
99 of 100 PubMed-indexed articles · 99% coverage · 2024–2025
No journal-level APC is available in the current OpenAlex snapshot. Cost is excluded from scoring.
Paste your title to see which of this journal's published topics it overlaps with. Your title stays in your browser for this preview and is not sent anywhere.
Want ranked journals with fit reasons, risks and a submission strategy instead? See a sample AI report.
Each spoke is a 0–100 percentile within a comparable journal cohort—not a percentage grade or a single black-box rating.
51 of 1,534 works · same type, year & subfield
0 works · same type, year & subfield
Below field-year expectation
of 1,473 topic-associated OpenAlex sources by lifetime output
FWCI compares papers with the same publication year, type, and field. 1.0 is the world average; above 1.0 is above expectation. This journal's median is 0.42, so its typical recent paper runs about 58% below its field benchmark.
3.3% of recent papers rank in the global top 10% after field normalization. This is easier to compare across specialties than raw citation totals.
Volume is separated from citation accumulation so newer papers are not presented as weaker simply because they are newer.
OpenAlex source records · 2016–2025
1,534 OpenAlex works · 2021–2024
OpenAlex topics show research communities; MeSH keeps the medical taxonomy recognizable.
Select a MeSH signal to see how much Journal of Cancer Research and Therapeutics publishes on it, from PubMed counts for the last five complete years.
Candidates share at least one OpenAlex subfield (or field, if too few do) with this journal's main research topics, ignoring generic catch-all topics, and are ordered by topic overlap, then current Journal Metrics Score.
* Cost is indicative only. APCs, taxes, waivers, and member discounts can change—always verify on the journal's official website.
| Category | Quartile |
|---|---|
| Otorhinolaryngology | Q2 |
| Radiation | Q3 |
| Hepatology | Q3 |
| Pulmonary and Respiratory Medicine | Q3 |
Confirm the exact title and ISSNs against the publisher homepage before a high-stakes submission decision.
Source: the current OpenAlex source record. OpenAlex works can include multiple work types. Fully Open Access is a source-level flag. Recent OA Works is summed from OpenAlex's counts_by_year series (up to the latest ten years); it is not a lifetime OA percentage. Any APC shown here is an indicative OpenAlex value—verify current charges on the journal's official website.
Journal of Cancer Research and Therapeutics' 2026 Journal Metrics Score is 1.4, from the August 2026 data release. The score is a two-year citation average computed from OpenAlex (CC0) data: citations received in the most recent complete year to works published in the two prior years, divided by the number of those works.
Journal of Cancer Research and Therapeutics' best quartile is Q2. By OpenAlex subfield: Q2 in Otorhinolaryngology; Q3 in Radiation; Q3 in Hepatology; Q3 in Pulmonary and Respiratory Medicine. Quartiles rank journals by Journal Metrics Score within each subfield.
No. Journal Metrics computes the score independently from OpenAlex open data. Other providers use different citation databases, document types, and counting rules, so their published figures for Journal of Cancer Research and Therapeutics will not match this score exactly. Compare journals using one source at a time.
Across 99 recent PubMed records with both dates, Journal of Cancer Research and Therapeutics took a median of 163 days from submission to acceptance; the middle half took 96–254 days. This interval includes editorial handling and revisions, so it is not the time to a first decision.
Comparable journals include Radiation Oncology Journal, Bmc Cancer, Radiology and Oncology, and Strahlentherapie Und Onkologie. Compare their scores, acceptance times, and costs in the recommended alternatives on this page before choosing where to submit.